Prandin

Indicated to address postprandial glycaemic elevations to manage type 2 diabetes and support mealtime insulin release.

Dosage

Pack size

You will receive a quality generic equivalent of Prandin, depending on stock.

Prescription and consultation requirements for Prandin vary by destination and are determined by the fulfilment partner.

Prandin details

Condition: Type 2 Diabetes Mellitus
Alternative names: repaglinide
Therapeutic class: Meglitinide
Pharmacological class: Antidiabetic
Minor side effects: nausea; headache; indigestion
Moderate side effects: hypoglycaemia; weight gain; diarrhoea
Serious side effects: severe hypoglycaemia, requires immediate medical attention
Dosage forms: Tablet
Administration route: Oral use
Supply category: Prescription-only medicine (POM)
Originator: Novo Nordisk
Onset Time: 30 minutes
Duration: 3–4 hours
Storage instructions: Store below 25°C.
Drug interactions: Gemfibrozil; Ketoconazole; Rifampin
Age restrictions: Approved for adults.

Contraindications

diabetic ketoacidosis; type 1 diabetes; concurrent gemfibrozil use; severe liver disease

Patient summary

indicated to address postprandial glycaemic elevations to manage type 2 diabetes and support mealtime insulin release.

Mechanism of action

Stimulates rapid insulin release from pancreatic beta cells by closing ATP-sensitive potassium channels.

Pregnancy and breastfeeding

TGA Category C: Use if clearly indicated. Insulin preferred in pregnancy. Breastfeeding: Not recommended.

Prandin is the originator brand name, made by Novo Nordisk. We use it to identify the medicine and are not affiliated with Novo Nordisk.

The fulfilment partner confirms whether the exact brand or an equivalent containing Repaglinide is offered.
The offered brand, manufacturer and dispatch location depend on the product, destination and partner warehouse.
Check the final product details at checkout before confirming an order.